Pamt Corp (PAMT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for October 31, 2024, to vote on key proposals including director elections, a new equity incentive plan, redomestication to Nevada, an increase in authorized shares, and auditor ratification.
Board recommends approval of all proposals, emphasizing benefits such as tax savings, governance flexibility, and enhanced director/officer protections from redomestication.
Shareholders of record as of September 5, 2024, are eligible to vote; proxy materials and annual report are available online.
Voting matters and shareholder proposals
Proposals include electing nine directors, approving the 2024 Equity Incentive Plan, redomestication to Nevada, increasing authorized common stock to 100 million shares, and ratifying Grant Thornton LLP as auditor.
Board recommends voting FOR all proposals; approval of share increase is contingent on redomestication approval.
Shareholder proposals for the 2025 meeting must comply with advance notice and SEC rules.
Board of directors and corporate governance
Board consists of nine members, with four meeting NASDAQ independence standards.
Controlled company status exempts from certain NASDAQ requirements; majority voting power held by Matthew T. Moroun and family trusts.
Board structure separates Chairman and CEO roles; active risk oversight through Audit Committee and full Board.
Board diversity matrix disclosed; code of ethics applies to all directors, officers, and employees.
Latest events from Pamt Corp
- Net loss narrowed to $7.4M as revenues rose and litigation risks remained high.PAMT
Q2 2026 - Net loss narrowed sharply in Q1 2026, aided by a significant property sale gain.PAMT
Q1 2026 - Board recommends approval of all proposals, including director elections and compensation.PAMT
Proxy filing - 2025 net loss deepened on lower revenues and a major auto-liability settlement; liquidity remains sufficient.PAMT
Q4 2025 - Annual meeting to vote on directors, equity plan, redomestication, and auditor ratification.PAMT
Proxy Filing - Key votes include director elections, equity plan, Nevada move, share increase, and auditor ratification.PAMT
Proxy Filing - Board seeks approval for director slate, auditor ratification, and highlights new equity plan.PAMT
Proxy Filing - Net loss of $5.6M in Q3 and 17.7% revenue drop as operating ratios worsened.PAMT
Q3 2025 - Revenue and profitability declined sharply in Q2 2025 amid persistent industry headwinds.PAMT
Q2 2025